Emerging insights into the molecular pathogenesis of uveal melanoma.
about
Frequent mutation of BAP1 in metastasizing uveal melanomasHistone deacetylase inhibitors induce growth arrest and differentiation in uveal melanomaMetastatic uveal melanoma: biology and emerging treatmentsUveal melanoma: From diagnosis to treatment and the science in between.Using risk factors for detection and prognostication of uveal melanomaCancer biomarker discovery: the entropic hallmark.A comparative transcriptomic analysis of uveal melanoma and normal uveal melanocyteUveal melanoma cell growth is inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase.Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization.New strategies in melanoma: molecular testing in advanced disease.The genetics of uveal melanoma: an emerging framework for targeted therapyRepression of genes involved in melanocyte differentiation in uveal melanoma.Targeted therapy for melanoma: a primer.A melanoma subtype: uveal melanoma.Genetics of primary intraocular tumorsNotch signaling promotes growth and invasion in uveal melanoma.Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanomaAssociation of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma.Skewed expression of the genes encoding epigenetic modifiers in high-risk uveal melanoma.Genetics of uveal melanoma and cutaneous melanoma: two of a kind?Implication of ultraviolet light in the etiology of uveal melanoma: A review.Genetic determinants of uveal melanoma.Suppression of α5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines.Cell growth inhibition in HPV 18 positive uveal melanoma cells by E6/E7 siRNA.A role for Jag2 in promoting uveal melanoma dissemination and growth.Uveal melanoma.Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.Hot issues in the current management of eye cancer.Uveal melanoma and GNA11 mutations: a new piece added to the puzzle.Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.Genetic prognostication in uveal melanoma.Prognostication for Uveal Melanoma: Are Two Tests Better than One?Uveal Melanoma with Histopathologic Intratumoral Heterogeneity Associated with Gene Expression Profile Discordance.BAP1 germline mutation in two first grade family members with uveal melanoma.Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions.A new mutation with staggering effects.New Cancer Stochastic Models Involving Both Hereditary and Nonhereditary Cancer Cases: A New Approach
P2860
Q24601069-FF790609-A8EA-46C2-A937-B319ADC16819Q24606279-8F1C4F30-39F0-4F95-B56A-8027A193E24EQ27028063-B798583B-9839-4D2C-868C-FA1F50963DF4Q30251762-8034CCFF-3FA6-40DD-9F93-2D3C99A4EE4BQ30414227-C93FAABE-0E88-42DD-B40B-F939D1EA8A2BQ30496149-AB68B5AD-B594-46E2-B40A-054FAC7A5733Q33815965-E402AC07-C6C4-421D-9569-C718C3CB9A5AQ33872396-25B42103-1499-4EE6-BA79-7D3481B9480AQ33925208-61D451AF-F799-4006-99E2-D50285A4881DQ33943660-A7311F39-5C14-483D-83EF-A46D6603EDDBQ34249080-289D0C00-326D-4374-B5F5-325ADEDE4D13Q34344533-077910BD-FA88-43B4-BCCA-E3781AAA7BCBQ34540273-9EA17AE5-11F2-48AC-912C-B7CDFC9E039AQ34988514-2C8920A3-F536-4CA6-9A61-EA0BEF748AB4Q36216850-FEBB2CDA-F7E5-48EF-B04A-3198615752C3Q36288207-9A69C4DE-2F30-4097-854F-48F47B6D5F79Q36545890-D7D357EB-8A17-48B3-AF18-E9004FD62663Q37118103-80D65652-ADED-4205-A11C-617260A68C63Q37404230-F1342D60-494B-4B64-B2B3-24032811CD20Q37772777-B8C19BE7-FC02-4143-B98F-E4C26F0B8089Q38131837-973E49D0-265E-4A86-8B46-6C67DB39A751Q38258203-3874A56D-4159-40DE-B532-0C7C39E92023Q38335089-9E1DCF3E-4C10-4826-8A85-DC8CCC80DD9EQ39180977-522A964C-6E81-40A7-8BB3-7D757D44F818Q39232343-08EECC42-F95B-447D-91C7-161D0D02C692Q39726923-795A3146-1C85-468D-A7A2-1B5BCD244B70Q42117021-7D0EFA6E-A1AE-4493-B5CF-E01869666675Q44672817-84220A00-6FC3-4F0F-A191-8E806002346DQ46943726-E5BE7458-9ADC-4C74-8495-8A11AE359890Q47692716-9D851707-C8BE-4853-8D30-EB1EF0A4C3A4Q47858202-EF252A7E-A0B3-46C9-A5F3-A025C9EC9A70Q49982759-33309F50-A977-4A53-9555-237BB2D37B18Q50227756-1E0640C9-8BDC-4F77-BAB3-4A1F25FAADF3Q54669259-552BA63F-3991-45F3-8B41-0E730C818AAAQ55333355-F3BB8CA9-A069-4BF4-B937-9439A8584C9CQ55462360-57627C87-8EB1-4561-85F1-A99AD56034B4Q59001485-F4B5284D-F0CF-48FA-B466-9C4BDEFF0EF4
P2860
Emerging insights into the molecular pathogenesis of uveal melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging insights into the molecular pathogenesis of uveal melanoma.
@en
Emerging insights into the molecular pathogenesis of uveal melanoma.
@nl
type
label
Emerging insights into the molecular pathogenesis of uveal melanoma.
@en
Emerging insights into the molecular pathogenesis of uveal melanoma.
@nl
prefLabel
Emerging insights into the molecular pathogenesis of uveal melanoma.
@en
Emerging insights into the molecular pathogenesis of uveal melanoma.
@nl
P2093
P2860
P356
P1433
P1476
Emerging insights into the molecular pathogenesis of uveal melanoma.
@en
P2093
J William Harbour
Olga A Agapova
Solange Landreville
P2860
P304
P356
10.2217/14796694.4.5.629
P407
P577
2008-10-01T00:00:00Z